Clinical Trials Directory

Trials / Completed

CompletedNCT01082900

Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial

Prophylactic CPAP/PEEP in Delivery Room (DR) Resuscitation, Effects on Natriuretic Peptide in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
138 (actual)
Sponsor
New York Hospital Queens · Academic / Other
Sex
All
Age
2 Minutes – 30 Minutes
Healthy volunteers
Accepted

Summary

Transient Tachypnea of the Newborn (TTN) is a disorder of delayed clearance of lung liquid and a common cause of admission of full term infants and late pre term infants (34 to 36 weeks) to Neonatal Intensive Care Units (NICU). Both late preterm gestational age at delivery, and mode of delivery are considered risk factors for TTN. The investigators hypothesize that CPAP administered prophylactically in the Delivery Room via a T piece based infant resuscitator Neopuff, to neonates at increased risk for TTN, would decrease the incidence of TTN and thus decrease the need for hospitalization in the NICU. This is a pilot study to evaluate the prophylactic administration of CPAP in the Delivery Room towards prevention of TTN and it's effects on natriuretic peptides.The study will be conducted as a randomized control trial after obtaining informed consents from the parents of eligible infants. Infants will be randomized to receive either experimental treatment (prophylactic CPAP) or standardized care.

Conditions

Interventions

TypeNameDescription
OTHERProphylactic CPAP AdministrationEXPERIMENTAL GROUP: Babies will receive prophylactic administration of CPAP (5 cm of H2O) in the Delivery Room via T piece (Neopuff) CONTROL GROUP: Provision of standard care in the Delivery Room

Timeline

Start date
2009-11-01
Primary completion
2013-01-01
Completion
2013-04-01
First posted
2010-03-09
Last updated
2015-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01082900. Inclusion in this directory is not an endorsement.